Pharmaceuticals, Biotechnology and Life Sciences
Addition to management team strengthens Lyndra’s development capabilities WATERTOWN, Mass.–(BUSINESS WIRE)–#CEO–Lyndra Therapeutics, the company making daily pills a thing of…
GENEVA & OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (“Takeda”) (TSE:4502/NYSE:TAK) today became the first private sector company to announce a…
• Pivotal Phase 3 data presented in ASCO oral session and simultaneously published in The Lancet • The Phase 3…
Subcutaneous formulation also showed reduced administration time and lower rates of infusion-related reactions compared to intravenous administration BEERSE, Belgium–(BUSINESS WIRE)–The…
Investigational treatment demonstrates favorable early safety and efficacy data in patients who had received a median five prior treatments including…
Investigational treatment demonstrates favorable early safety and efficacy data in patients who had received a median five prior treatments including…
Integrated efficacy and safety results in 643 patients were consistent with individual trial results (ADVANCE and RECOVER) The integrated data…
DCVAC/LuCa decreased the risk of death in patients with stage IV NSCLC by 46% Median overall survival (OS) reached 15.5…
Data presented at ASCO 2019 showed 57% of patients alive at three years vs. 43.5% on placebo WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca…
LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, will present updated interim results from a Phase II clinical…